Lexogen
PrivateLast Round
Grant
Apr 29, 2020
Total Funding Raised
$13,000
Momentum Score
25 /100
Company Overview
Lexogen is a biotechnology company that develops and sells technologies and kits for RNA analysis and offers end-to-end Next-Generation Sequencing (NGS) services.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales, Government Contracts
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lexogen Comps
Public and private peers based on sector, stage, and business model.
Lexogen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 29, 2020 | ||||
| Grant | Jan 1, 2012 | ||||
| Accelerator | Aug 1, 2007 |
Key People
Founding team and executive leadership
Lexogen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Austria Wirtschaftsservice | Seed |
| FFG Austrian Research Promotion Agency | Grant |
| INiTS | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 26, 2026
Monthly visitors increased 31% MoM to 21.6K.
- Nov 11, 2024
Monthly visitors increased 38% MoM to 24.9K.
Lexogen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lexogen's valuation, stock price, and market status.
